Evidence map›Paper›PMID 33907842›Full record

ArticleOncology reports2021

LOXL1‑AS1 promotes thymoma and thymic carcinoma progression by regulating miR‑525‑5p‑

Jin Wang, Haihua Huang, Xiaomiao Zhang, Haitao Ma

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Thymic Epithelial Neoplasms: Focusing on the Epigenetic Alterations.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jin WangDepartment of Cardiothoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Haihua HuangDepartment of Thoracic Surgery, Shanghai General Hospital, Shanghai 200080, P.R. China.
Xiaomiao ZhangDepartment of Thoracic Surgery, Shanghai General Hospital, Shanghai 200080, P.R. China.
Haitao MaDepartment of Cardiothoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Shanghai First People's Hospital · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the lack of specific symptoms in early thymic epithelial tumours (TETs), patients are mostly in the advanced stage at the time of presentation. The aim of the present study was to explore the mechanism by which the long noncoding RNA (lncRNA) LOXL1‑AS1 affects thymoma and thymic carcinoma progression by targeting the miR‑525‑5p‑

Indexed as

3' Untranslated RegionsAnimalsApoptosisCell Line, TumorComputational BiologyGene Expression Regulation, NeoplasticGene Knockdown TechniquesHSP70 Heat-Shock ProteinsHumansMiceMicroRNAsMitochondrial ProteinsNeoplasm InvasivenessPrognosisRNA, Long NoncodingSurvival Rate3' Untranslated RegionsHSP70 Heat-Shock ProteinsHSPA9 protein, humanMicroRNAsMIRN525 microRNA, humanMitochondrial ProteinsRNA, Long Noncodingcompeting endogenous RNAHSPA9long non‑coding RNA LOXL1‑AS1microRNA‑525‑5pthymic carcinomathymic epithelial tumoursthymoma

Identifiers

PMID33907842
PMCPMC8107651
OpenAlexW3159532307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.